Uterine myomas: an overview of development, clinical features, and management.
about
Minimally invasive surgical techniques versus open myomectomy for uterine fibroidsSelective progesterone receptor modulators (SPRMs) for uterine fibroidsProgestogens or progestogen-releasing intrauterine systems for uterine fibroidsMinimally invasive surgical techniques versus open myomectomy for uterine fibroidsMifepristone for uterine fibroidsAromatase inhibitors for uterine fibroidsProgestogens or progestogen-releasing intrauterine systems for uterine fibroidsAromatase inhibitors for uterine fibroidsDanazol for uterine fibroidsDanazol for uterine fibroidsMifepristone for uterine fibroidsCharacterization of antiestrogenic activity of the Chinese herb, prunella vulgaris, using in vitro and in vivo (Mouse Xenograft) modelsEpidemiology of Uterine Myomas: A ReviewThe clinical pharmacology and pharmacokinetics of ulipristal acetate for the treatment of uterine fibroidsEpidemiology of uterine fibroids: a systematic review.High-Intensity Focused Ultrasound Ablation of Uterine Fibroids - Potential Impact on Fertility and Pregnancy Outcome.Uterine fibroids: current perspectivesRadiological appearances of uterine fibroids.Inhibition of canonical WNT signaling attenuates human leiomyoma cell growth5-Hydroxymethylcytosine promotes proliferation of human uterine leiomyoma: a biological link to a new epigenetic modification in benign tumors.Hysterosalpingographic findings among Ghanaian women undergoing infertility work-up: a study at the Korle-Bu Teaching Hospital.RETRACTED: The efficiency and safety of tranexamic acid for reducing blood loss in open myomectomy: A meta-analysis of randomized controlled trialsPatient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysisFeasibility study on energy prediction of microwave ablation upon uterine adenomyosis and leiomyomas by MRIMED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas.Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma.Role of stem cells in human uterine leiomyoma growth.Research of dose-effect relationship parameters of percutaneous microwave ablation for uterine leiomyomas--a quantitative study.The Relationship between Uterine Myoma Growth and the Endocrine Disruptor in Postmenopausal Women.Clinical care of patients undergoing uterine artery embolization.Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.Tranexamic acid for the management of uterine fibroid tumors: A systematic review of the current evidence.Increased urinary cobalt and whole blood concentrations of cadmium and lead in women with uterine leiomyomata: Findings from the ENDO Study.Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity.Prevalence of uterine leiomyomas in lymphangioleiomyomatosisGrowth factors and myometrium: biological effects in uterine fibroid and possible clinical implicationsUterine fibroid embolization for symptomatic fibroids: study at a teaching hospital in kenya.Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management.Uterine fibroids: Which treatment?Indications and outcome of abdominal myomectomy in University of Maiduguri Teaching Hospital: Review of ten year
P2860
Q24193090-D96E7A78-AC27-4E21-9824-561C20CA4CBBQ24197801-E19E1B75-C013-4BF3-B007-ECC8C8698F2CQ24200693-41AB32CF-3F27-4578-9E87-EBD6D6E91FB1Q24200726-61CD144B-1848-420F-8A13-586F5C6D2E17Q24201506-9311C64E-5B1B-4AAD-B19E-7A7CE7DF41B4Q24202922-224FC97B-C11B-4D55-911F-27EE25A0312FQ24234601-9B6BE4EF-7C13-43B9-8EF1-187088CF1AEBQ24234688-3967B8A1-EBDA-46E4-B76A-617EDA6D5590Q24239837-5B4A2AEF-F5B5-4507-8C06-F76EA25EED9DQ24240341-979BA33F-4C34-4ADD-9305-48D942F92533Q24241937-A279F020-01EC-4B05-ADA1-B34F83D89706Q24652129-CBDA5F84-98E6-4CB2-832B-A22F5FA304DCQ26764887-DAA5884A-13BF-4BFA-8483-11922B85393CQ26998672-3899165A-721D-4C33-9D6C-1B4962932496Q30235265-260D244C-2B3D-43C3-BF61-3405F3387396Q30440177-59466D16-2E2C-4D8E-A18E-44F3A644E853Q30443242-DC464536-B714-44B5-9093-5C48E59BF05CQ30485223-D5A619B6-0C4D-421D-B9C7-888B3D392FD8Q33560729-63E2B73F-77EB-48A2-A50D-DCA4EEF9048EQ33570198-675E4EE7-B364-4E75-9660-E3964B0A3D1DQ33655354-211B0342-F91E-4691-A903-4EC6216B6571Q33783408-27DDCB58-FC84-4BFE-9BE3-51A1ECFD3892Q33812716-A463B72E-1F2F-4726-9DCF-5EB4AA3AA275Q33956278-30AE4806-9506-4338-90F2-DE3F9F2B1480Q34210977-92C2AA3F-4AE8-4882-BAF7-A8A36C3D33F7Q34223004-3D0C635C-9238-482E-9168-54478C829261Q34263429-41B654D5-8747-43B5-8370-DE3573B077FCQ34264439-3377B6E8-210B-4012-BD6F-EB3D81350DFCQ34442909-8F683FE9-B859-48A9-8E20-D0EC6989CF70Q34563500-4DA4380A-A936-43C4-8D58-6470F3C7BD8AQ34674982-5F928257-64C2-4675-BB81-850F6D48ADAFQ34706222-6309E8EE-8F0C-44A3-BEAD-4811D3DC0D28Q34791325-C9B121DA-187B-43E9-90E5-DBDEFD366554Q35023826-6043D122-0BB5-44BC-8BF3-3E8F496C5E8EQ35190953-DF09D13F-7884-4206-A13D-3C69AF4CE8C5Q35328276-0D11AF2B-C0F3-40F9-8BC0-2B8D47856215Q35355480-3EE6762B-06C1-4121-BA8C-7626290E82CFQ35531880-9909B632-1C39-4D5C-8305-EC043C6FA57BQ35542935-B28660B5-E83F-4B99-BE4B-876F7E1C19FBQ35542988-4312947C-3751-476D-BBCB-C5A972B05CA8
P2860
Uterine myomas: an overview of development, clinical features, and management.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Uterine myomas: an overview of development, clinical features, and management.
@ast
Uterine myomas: an overview of development, clinical features, and management.
@en
type
label
Uterine myomas: an overview of development, clinical features, and management.
@ast
Uterine myomas: an overview of development, clinical features, and management.
@en
prefLabel
Uterine myomas: an overview of development, clinical features, and management.
@ast
Uterine myomas: an overview of development, clinical features, and management.
@en
P1476
Uterine myomas: an overview of development, clinical features, and management.
@en
P2093
Edward E Wallach
Nikos F Vlahos
P304
P356
10.1097/01.AOG.0000136079.62513.39
P407
P577
2004-08-01T00:00:00Z